We are excited to welcome Dr. Polymnia Louka to the Translational Neuropharmacology Lab as an ONISILOS Marie Skłodowska-Curie Fellow. Her research focuses on the effects of ketamine’s enantiomers and active metabolites on depression-induced bone impairment, aiming to uncover novel therapeutic interventions at the intersection of neuropharmacology, bone biology, and imaging.

Dr. Louka has a diverse background in medical engineering, advanced neuroimaging, and bone biology, with expertise in bone physiology, Micro-CT imaging, and musculoskeletal research. Before joining the lab, she worked in both academia and the pharmaceutical industry, managing  clinical trials and contributing to EU-funded research projects.

Welcome Dr. Louka to the Zanos lab!